Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jan, 4 2026
Dec, 12 2025
Jan, 20 2026
Sep, 1 2025
Sep, 1 2026